In a news release quietly published June 29, 2022, the U.S. Department of Health and Human Services announced that it, in partnership with the Department of Defense, agreed to purchase another 105 million doses of Pfizer’s COVID-19 shot — for $ 3.2 billion.1 The contract is intended to supply shots for a coming fall injection… Read More: US Gives Pfizer $3.2 Billion for Ineffective COVID Vax »
In a rather shocking turn of events, the U.S. Food and Drug Administration sneaked in a “Future Framework”1 scheme that will allow Pfizer and Moderna to reformulate and release updated COVID shots without conducting any additional human clinical trials, other than what’s already been done.2,3,4 FDA Rewrites the Rules on the Fly A vote on… Read More: How Vaccine Trials Routinely Rig the Results »
7 July 2022 – London, UK – Crossword Cybersecurity Plc (AIM:CCS, “Crossword”, the “Company” or the “Group”), the cybersecurity solutions company focused on cyber strategy and risk, is pleased to announce that its Identiproof verifiable credentials (VC) product has successfully achieved its first milestone at the recently held Jobs for the Future (JFF) Plugfest. The… Read More: Crossword Cybersecurity’s Identiproof demonstrates early commitment to Open Badges V3… »
The quality management system of the biotechnology company complies with the European in-vitro Diagnostic Regulation (IVDR) Darmstadt, June 30, 2022 – Quality orientation is an integral part of the culture and processes at R-Biopharm AG. The biotechnology company from southern Hesse thus ensures that quality is integrated throughout the entire company and continually improved in… Read More: R-Biopharm is IVDR certified »